The ARK Israel Innovative Technology ETF (IZRL) seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index, which is designed to track the price movements of exchange-listed Israeli companies whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology.
The Index is designed to track the price movements of exchange-listed Israeli Companies whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology. The Index includes equity securities and depositary receipts of exchange-listed companies that are incorporated and/or domiciled in Israel (‘‘Israeli Companies’’) and are included in one of the following economic sectors as defined by FactSet Research Systems:
|IZRL||1 Year||3 Years||5 Years||Since Inception|
|IZRL||1 Months||3 Months||YTD||Since Inception|
|IZRL||2018 Year||2019 Year||2020 Year||2021 Year||2022 Year|
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. Extraordinary performance is attributable in part due to unusually favorable market conditions and may not be repeated or consistently achieved in the future. The Fund’s most recent month-end performance can be found in the fund material section. Returns for less than one year are not annualized. Net asset value (“NAV”) returns are based on the dollar value of a single share of the ETF, calculated using the value of the underlying assets of the ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times. Total Return reflects the reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of the ETF’s shares may differ significantly from their NAV during periods of market volatility.
|Ticker||Name||Market Value||Weight (%)|
|FVRR||FIVERR INTERNATIONAL LTD'||$3,151,430.28||2.90%|
|URGN UQ||UROGEN PHARMA LTD'||$2,971,322.60||2.74%|
|MBLY||MOBILEYE GLOBAL INC-A'||$2,818,733.86||2.60%|
|CLBT||CELLEBRITE DI LTD'||$2,805,493.64||2.58%|
Weight % of Market Value
|Africa / Middle East||
Weight % of Market Value
|Large ($10 - $100B)||
|Medium ($2 - $10B)||
|Small ($300M - $2B)||
|Micro ($50 - $300M)||
Portfolio holdings and allocations are subject to change and should not be considered investment advice or a recommendation to buy, sell or hold any particular security.
The Premium/Discount chart shows the difference between the daily market price of the Fund’s shares and the Fund’s net asset value (“NAV”). The daily market price is calculated using the mid-point between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund’s NAV is calculated (usually 4:00 pm Eastern time). The vertical axis of the chart shows the premium or discount of the Mid-Point price as a percentage of the NAV. The horizontal axis shows the number of trading days covered by the chart, and each bar in the chart demonstrates how many days the Fund traded within the given premium/discount range. The data presented in the chart and table above represent past performance and cannot be used to predict future results.
The principal risks of investing in IZRL: Equity Securities Risk. The value of the equity securities the Fund holds may fall due to general market and economic conditions. Foreign Securities Risk. Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities. Index Tracking Risk. The returns of the ETF may not match the returns of the underlying index that the ETF is designed to track. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Innovative Technology Risk. Companies that are developing innovative technologies may not be able to capitalize on the technology and may face political or legal attacks from competitors, industry groups or local and national governments. Detailed information regarding the specific risks of IZRL ETF can be found in the prospectus. Additional risks of investing in IZRL include equity, market, management, and non-diversification risks, as well as fluctuations in market value and NAV. An investment in an ETF is subject to risks, and you can lose money on your investment in an ETF. There can be no assurance that the ETF will achieve its investment objective. The ETF’s portfolio is more volatile than broad market averages. Shares of IZRL are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. ETF shares may only be redeemed directly with the ETF at NAV by Authorized Participants in very large creation units. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions, and frequent trading may incur brokerage costs that detract significantly from investment returns.